Past Gallery


On the tremendous success of 1st &2nd conferences on Dementia, we are announccing "3rd Innovations and state of the Art In Alzheimer's & Dementia Research" which will take place in the gorgeous city of London, UK during July18-20, 2019.

A special invitation is extended to international colleagues to attend and contribute to the conference. Mark your calendars now and for more details please contact us at





To Meet renowned speakers, world's leading CEO's, Directors, decision and policy makers. To know about the ongoing research projects for Alzheimer's & Dementia. To keep abreast of all advances in Alzheimer's & Dementia. Chance to collaborate research organizations with industries. To share the research ideas and implement them in Alzheimer's & Dementia. Best opportunity to reach the largest assemblage of participants from Alzheimer's & Dementia Societies.



Our conferences are about you, our clients, so we work for unqualified success and we do that quietly, professionally and impeccably. We've built a reputation for creating and delivering inspirational conferences and executing them flawlessly first time round. We work really hard to achieve this and our success is down to the dynamics of a team who are down-to-earth.



INNOVINC conferences cover a broad range of research in the area of life science and technology. Attending a Innovinc Conference will provide immense access to ground-breaking research presentations and discussions which provides the best break to develop collaborations, get innovative ideas and opportunity for your own work.


About Conference

3rd Innovations and State of the Art In Alzheimer’s & Dementia Research (ISAADR-2019)

On the successful of our previous year conferences, Innovinc International welcomes you to attend the ISAADR-2019 during July 18 - 20, 2019 at London, UK.

Alzheimer’s & Dementia Research -2019 anticipates more than 200 participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Neurologists, Psychiatrist, Neuroscientists, Nutritional Scientists, Neurosurgeons, Healthcare clinicians, Researchers.

This International ISAADR-2019 conference brings together researchers, educators and practitioners representing research and educational institutions, hospitals, associations and consulting organizations from all over the world to exchange ideas, to define the research priorities in the fields of Alzheimer’s & Dementia Research.

  • slider-home
  • slider-home
  • slider-home

Scientific Sessions

We invite you to submit your abstract in relation to research and proficiency in Alzheimer’s & Dementia. Abstracts of all the related interest areas are accepted, but are not limited to the following sessions:

Why to Attend

Innovinc International welcomes you to attend the 3rd Innovations and state of the Art In Alzheimer's & Dementia Reserach during July 18 - 20, 2019,at London, UK. To meet renowned speakers, world's leading CEO's, Directors, decision and policy makers.

To know about the ongoing research projects on Alzheimer's & Dementia and to share the research ideas and implement them in Alzheimer's & Dementia. New contacts to enhance the business opportunities. Engage with high profile international and national speakers




day 1 agenda

Thu , Jul 18, 2019

  • 08:30 - 09:15
  • Registrations

  • 09:15 - 09:30
  • Introduction & Opening Ceremony

  • 09:30 - 10:00
  • Keynote Talk-1

    Title: The impact of dementia on UK Black, Asian and minority ethnic communities
    David Truswell,
    Dementia Alliance for Culture and Ethnicity, UK

  • 10:00 - 10:30
  • Keynote talk-2

    Title: Omental Transposition to the Brain for Alzheimer’s Disease
    Harry S. Goldsmith, University of California, Davis, USA

  • 10:30 - 11:00
  • Keynote talk-3

    Title: Functional cognitive disorder; new insights from cognitive data in fibromyalgia and chronic fatigue syndrome

    Jeremy D Isaacs, St George’s University of London, UK

  • 11:00
  • Refreshments

  • 11:10
  • Group Photo

  • 11:15 - 13:15
  • Scientific Session 1

    Title: The Utility Of Polygenic Risk Scores To Identify Individuals For Risk Of Cognitive Decline And Alzheimer’s Disease: New Opportunities For Clinical Trial Design
    Richard Pither, Cytox Ltd, united kingdom

    Title: Atypical presentation of Alzheimer’s disease – diagnosis and management

    Chuang-Kuo Wu, University of California - Irvine School of Medicine, United States

    Title: Development of skin biomarkers as a rapid and least invasive diagnostic test for  Alzheimer’s and other neurodegenerative diseases
    Wenquan Zou, Case Western Reserve University School of Medicine, USA

    Title: The Dementia Care in Hospitals Program – A National Program to improve hospital care for patients with cognitive impairment.

    Mark Yates, Ballarat Innovation and Research Collaboration for Health, Deakin University, Australia

    Title: Structural effects of phosphorylation and the R406W mutation on tau
    Neal Zondlo,  University of Delaware, United States

    Title: Transcranial Magnetic Stimulation markers represent an innovative approach for the diagnosis of Prodromal Alzheimer Disease
    Alessandro Padovani, University of Brescia, Italy

  • 13:15 - 14:05
  • Lunch With Round table Discussions

  • 14:05 - 16:05
  • Scientific Session 2

    Title: Putative diet and lifestyle risk factors in Dementia and cognitive impairment

    Douglas Wardell Wilson, Formerly Durham (UK) and Swansea (Wales), United Kingdom

    Title:Comparison of cholinergic status with quantitative EEG in healthy subjects and patients suspected of dementia.
    Rolf Ekedahl, NeuFydi, Sweden

    Title: Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis

    Chin-Hsiao Tseng, National Taiwan University Hospital, Taiwan

    Title: Neurotrophic factor a-1 gene mutation in AD patient leads to dementia and depression in mice
    Loh, Y Peng, National Institutes of Health, USA

    Title: Antidepressants, AKA1 and AKA5, increase  -amyloid deposition in APPswe/PSEN1dE9 transgenic mice
    Shing-Chuan Shen, Taipei Medical University, Taiwan

    Title: TREM2: Ramifications for hiPSC-Microglial functionality in AD
    Jennifer Pocock, Queen Square Institute of Neurology, United Kingdom


  • 16:05
  • Refreshments

  • 16:15 - 17:15
  • Scientific Session 3

    Title: Pterosins inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases via specific structure-activity relationship with a strong BBB permeability

    Gil Hong Park, Korea University College of Medicine, South Korea

    Title: Role of the whole-exome sequencing analysis in the diagnosis of clinically heterogeneous families with ataxia.

    Marta Lenska-Mieciek, Centre of Postgraduate Medical Education, Warsaw, Poland

    Title: The impact of virtual memory palaces on well-being with dementia

    Kasper Bormans, University of Leuven, Belgium


  • 17:15
  • Finalized program

day 2 agenda

Fri , Jul 19, 2019

  • 10:00 - 11:00
  • Scientific Sessions

    Title: Synaptic dysfunction in dementia: JNK’s role
    Tiziana Borsello,  Università degli Studi di Milano, Italy

    Title: DNA Polymerase as Therapeutic Intervention for Treating Patients with Multiple Sclerosis.          
    Sherif Salah Abdelaziz Hesen, Cairo University, Egypt

    Title: Computer-aided diagnosis of Alzheimer’s Disease on Positron Emitting Tomoraphy brain images.
    Mouloud ADEL, Aix-Marseille University, France

  • 11:00
  • Refreshments

  • 11:15 - 12:15
  • Scientific Sessions

    Title: Alzheimer’s patients induced pluripotent stem cells form 3D mature neural cultures to model biochemical aspects of the disease pathology
    Sandrine Willaime-Morawek, University of Southampton, UK

    Title: Therapeutic Benefits of the Camelid-Derived Antibodies in a Human Induced Pluripotent Stem Cells Derived from an Alzheimer’s Disease Patient
    Utpal Kumar Adhikari, Western Sydney University, Australia

    Title: Mechanistic approach to higher rate of AD among Arctic populations: activation of brain inflammatory pathways by elevated 2,3,7,8-TCDD body burdens.
    Ilya B. Tsyrlov, Xenotox. Inc, United States

  • 12:15 - 12:45
  • Poster Presentation

    Title: Olive oil consumption and cognition in older adults. Systematic review 
    Felix Bermejo-Pareja, Complutense University, Spain

    Title: Is clinical subtyping useful for mild cognitive impairment nosology? Data from the NEDICES cohort.
    Felix Bermejo-Pareja, Complutense University, Spain

  • 12:45 - 13:30
  • Lunch With Round table Discussions

  • 13:30 - 15:00
  • keynote Sessions

    Title: Novel biologics reverse cognitive function deficits and amyloid plaques in Alzheimer’s disease animal models.

    Mourad Tayebi, Western Sydney University, Australia

    Title: To identify the challenges and solutions facing individuals with dementia and their family carers living in rural communities, and provide solutions.
    Ian Kenneth Grant Sherriff, Plymouth University Faculty of Medicine and Dentistry, United Kingdom

    Title: Silicic acid and beer consumption reverses the metal imbalance and the prooxidant status induced by aluminum nitrate in mouse brain

    Francisco José Sánchez Muniz, Complutense University, Madrid, Spain


  • 15:00 - 17:10
  • Scientific Sessions

    Title: Regulatory Mechanism of miR-543-3p on GLT‑1 in a Mouse Model of Parkinson’s Disease
    Shaogang Qu, Shunde Hospital, Southern Medical University, China

    Title: Crucial role of mitofilin and cyclophilin D interaction in post-ischemic GPER1-induced protection against cell death.​
    Jean C Bopassa, University of Texas Health Science San Antonio School of Medicine, USA

    Title: APOE4 Polymorphism and The Pattern of  FTIR  Spectra  in Patients with  Alzheimer’s disease
    Sarawut Suksuphew, Suranaree University of Technology, Thailand

    Title: Optical detection of Alzheimer’s disease in mice with single domain antibody fragments.
    Umma Habiba, Western Sydney University, Australia

    Title: Antidepressants, AKA1 and AKA5, induced intestinal microbial dysbiosis is associated with increased risk of Alzheimer’s disease
    Ming-Hsuan Liao, Taipei Medical University, Taiwan

    Title: Interaction between Herpes Simplex Virus type 1 and APOE4 in the onset of Alzheimer’s disease in the Three-City prospective cohort study
    Linard Morgane, Inserm Bordeaux Population Health, France

  • 17:10 - 17:30
  • Video presentation

    Title: Nose-to-Brain Nerve Growth Factor Delivery to Protect the Human Brain in Frontotemporal Dementia associated with Corticobasal Syndrome: A Pilot Study

    Alberto de bellis, Maria Rosaria Maglione Foundation, Italy

day 3 agenda

Sat , Jul 20, 2019

  • 10:00
  • Scientific Sessions

  • 10:45
  • Refreshments

  • 11:00
  • Scientific Sessions

  • 13:15
  • Lunch

  • 14:00
  • Round table Discussions

  • 16:00
  • Refreshments

  • 16:15
  • Closing Ceremony

posters agenda

Tue , Oct 15, 2019

  • 14:00
  • Poster Presentations

    Title: Olive oil consumption and cognition in older adults. Systematic review 
    Felix Bermejo-Pareja, Complutense University, Spain

    Title: Is clinical subtyping useful for mild cognitive impairment nosology? Data from the NEDICES cohort.
    Felix Bermejo-Pareja, Complutense University, Spain

Tentative Program


Don t Miss This Amazing Conference And Opportunities

Past Conference Gallery

Promote Partners